Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure

Abstract

In this cohort study, patients who initiated empagliflozin were less likely to experience the composite of all-cause mortality or hospitalization compared with patients who started dapagliflozin. Additional studies are needed to confirm these finding.